Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-24 Exercise | 2024-07-26 4:15 pm | 2019-07-25 2024-07-25 | Lantern Pharma Inc. | LTRN | KEYSER D JEFFREY Director | 3,832 | $0 | 0 (Direct) | View |
| 2024-07-24 Exercise | 2024-07-26 4:15 pm | N/A N/A | Lantern Pharma Inc. | LTRN | KEYSER D JEFFREY Director | 3,832 | $3.13 | 0 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | SHARMA PANNA President and CEO | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | Maccecchini Maria-Luisa Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | KEYSER D JEFFREY Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | Margrave David R. Chief Financial Officer | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | Chandru Vijay Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | Bhatia Kishor G. Chief Scientific Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | Lantern Pharma Inc. | LTRN | Silberstein David S. Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-01-17 Exercise | 2024-01-19 4:31 pm | 2019-03-07 2024-03-07 | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 79,021 | $0 | 784,013 (Indirect) | View |
| 2024-01-17 Exercise | 2024-01-19 4:31 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 79,021 | $3.13 | 784,013 (Indirect) | View |
| 2024-01-17 Exercise | 2024-01-19 4:30 pm | 2019-03-07 2024-03-07 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 79,021 | $0 | 784,013 (Indirect) | View |
| 2024-01-17 Exercise | 2024-01-19 4:30 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 79,021 | $3.13 | 784,013 (Indirect) | View |
| 2022-10-20 Option Award | 2022-10-24 5:57 pm | N/A 2032-10-19 | Lantern Pharma Inc. | LTRN | Maccecchini Maria-Luisa Director | 3,200 | $0 | 3,200 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:55 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 32,538 | $1.03 | 1,889,456 (Indirect) | View |
| 2022-09-02 Exercise | 2022-09-07 4:55 pm | 2018-12-17 2028-12-16 | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 32,538 | $0 | 1,889,456 (Indirect) | View |
| 2022-09-02 Exercise | 2022-09-07 4:54 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 32,538 | $1.03 | 1,889,456 (Indirect) | View |
| 2022-09-02 Exercise | 2022-09-07 4:54 pm | 2018-12-17 2028-12-16 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 32,538 | $0 | 1,889,456 (Indirect) | View |
| 2022-08-06 Option Award | 2022-08-09 4:26 pm | N/A 2032-08-06 | Lantern Pharma Inc. | LTRN | SHARMA PANNA President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-17 Exercise | 2022-03-21 6:11 pm | 2017-03-17 2022-03-17 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Bios Equity Partners LP Cavu Management LP BIOS Capital Management LP Cavu Advisors LLC BIOS Advisors GP LLC Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP Director 10% Owner | 95,779 | $0 | 1,292,887 (Indirect) | View |
| 2022-03-17 Exercise | 2022-03-21 6:11 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Bios Equity Partners LP Cavu Management LP BIOS Capital Management LP Cavu Advisors LLC BIOS Advisors GP LLC Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP Director 10% Owner | 95,779 | $3.13 | 1,292,887 (Indirect) | View |
| 2021-11-04 Option Award | 2021-11-08 5:23 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. BP Directors LP Bios Equity Partners LP Cavu Management LP BIOS Capital Management LP Cavu Advisors LLC BIOS Advisors GP LLC Fletcher Aaron G.L. Director 10% Owner | 3,200 | $0 | 1,764,346 (Indirect) | View |
| 2021-11-04 Option Award | 2021-11-08 4:05 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | PRENDERGAST FRANKLYN G Director | 3,200 | $0 | 3,200 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:05 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | Chandru Vijay Director | 3,200 | $0 | 3,200 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:05 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | Silberstein David S. Director | 3,200 | $0 | 3,200 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:05 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | KEYSER D JEFFREY Director | 3,200 | $0 | 3,200 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-02 4:06 pm | N/A 2031-10-29 | Lantern Pharma Inc. | LTRN | Bhatia Kishor G. Chief Scientific Officer | 17,400 | $0 | 17,400 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-02 4:05 pm | N/A 2031-10-29 | Lantern Pharma Inc. | LTRN | Margrave David R. Chief Financial Officer | 26,100 | $0 | 26,100 (Direct) | View |
| 2020-06-15 Conversion | 2020-06-17 5:35 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Green Park & Golf Ventures II LLC GPG LPI Investment LLC Lantern 3-19 Investment LLC Health Wildcatters Fund II LLC Health Wildcatters LLC Green Park & Golf Ventures LLC Garcia Gilbert G. II Heighten Clay M Soderstrom Carl D 10% Owner | 733,560 | $0 | 131,697 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-16 7:30 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 2,293,804 | $0 | 98,657 (Indirect) | View |
| 2020-06-15 Other | 2020-06-16 7:30 pm | N/A 2030-06-14 | Lantern Pharma Inc. | LTRN | Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 9,135 | $0 | 98,657 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-16 6:21 pm | N/A 2030-06-14 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP Director 10% Owner | 9,135 | $0 | 98,657 (Direct) | View |
| 2020-06-15 Conversion | 2020-06-16 6:21 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP Director 10% Owner | 2,293,804 | $0 | 98,657 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-15 5:35 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Chandru Vijay Director | 9,135 | $0 | 9,135 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-15 5:34 pm | N/A N/A | Lantern Pharma Inc. | LTRN | SHARMA PANNA CEO & President | 76,628 | $0 | 76,628 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-15 5:34 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Bhatia Kishor G. Chief Scientific Officer | 52,200 | $0 | 52,200 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-15 5:33 pm | N/A N/A | Lantern Pharma Inc. | LTRN | PRENDERGAST FRANKLYN G Director | 9,135 | $0 | 9,135 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-15 5:33 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Silberstein David S. Director 10% Owner | 9,135 | $0 | 9,135 (Direct) | View |